Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Apr;127(4):703-12.
doi: 10.1542/peds.2010-1468. Epub 2011 Mar 28.

State laws regarding the retention and use of residual newborn screening blood samples

Michelle H Lewis  1 , Aaron Goldenberg, Rebecca Anderson, Erin Rothwell, Jeffrey Botkin
Affiliations

State laws regarding the retention and use of residual newborn screening blood samples

Michelle H Lewis et al. Pediatrics. 2011 Apr.

Abstract

Background: After newborn screening has been completed, many states retain residual newborn screening dried blood samples for various purposes, including program evaluation, quality assurance, and biomedical research. The extent to which states possess legal authority to retain residual dried blood samples (DBS) and use them for purposes unrelated to newborn screening is unclear.

Objective: The purpose of this study was to evaluate state laws regarding the retention and use of DBS.

Methods: State statutes and regulations related to newborn screening of all 50 states plus the District of Columbia were accessed online between November 2008 and December 2009 and reviewed by 2 independent reviewers to determine the extent to which the retention and use of DBS were addressed.

Results: The retention or use of DBS has not been addressed in 18 states. In 4 states, DBS becomes state property. Eight states require that parents be provided information regarding the retention of DBS. Parents in 5 states may request the destruction of their child's residual sample. Parental consent is required under certain circumstances to release DBS for research in 6 states. One state prohibits DBS from being used for research purposes.

Conclusions: States have wide variability in their policies regarding the retention and use of DBS. Many states have not addressed key issues, and some states that retain DBS may be acting outside the scope of their legal authority. The lack of transparency on the part of states in retaining DBS may undermine public trust in state newborn screening programs and the research enterprise.

PubMed Disclaimer

References

    1. American Academy of Pediatrics/Health Resources and Services Administration Newborn Screening Task Force Serving the family from birth to the medical home: newborn screening: a blueprint for the future: a call for a national agenda on state newborn screening programs. Pediatrics. 2000;106(2 pt 2):389–422 - PubMed
    1. Watson MS, Lloyd-Puryear MA, Mann MY, Rinaldo P, Howell RR. Newborn screening: toward a uniform screening panel and system. Genet Med. 2006;8(suppl 1):1S–252S - PMC - PubMed
    1. Mandl KD, Feit S, Larson C, Kohane IS. Newborn screening program practices in the United States: notification, research, and consent. Pediatrics. 2002;109(2):269–273 - PubMed
    1. Olney RS, Moore CA, Ojodu JA, et al. Storage and use of residual dried blood spots from state newborn screening programs. J Pediatr. 2006;148(5):618–622 - PubMed
    1. Sheman GG, Stevens G, Jones SA, Horsfield P, Stevens WS. Dried blood spots improve access to HIV diagnosis and care for infants in low-resource settings. J AIDS. 2005;38(5):615–617 - PubMed

Publication types

MeSH terms